These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27467088)

  • 21. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes.
    Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico modeling to predict drug-induced phospholipidosis.
    Choi SS; Kim JS; Valerio LG; Sadrieh N
    Toxicol Appl Pharmacol; 2013 Jun; 269(2):195-204. PubMed ID: 23541745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different Sensitivity of Macrophages to Phospholipidosis Induction by Amphiphilic Cationic Drugs.
    Öhlinger K; Absenger-Novak M; Meindl C; Ober J; Fröhlich E
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring the accumulation of fluorescently labeled phospholipids in cell cultures provides an accurate screen for drugs that induce phospholipidosis.
    Nioi P; Pardo ID; Snyder RD
    Drug Chem Toxicol; 2008; 31(4):515-28. PubMed ID: 18850360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells.
    Atienzar F; Gerets H; Dufrane S; Tilmant K; Cornet M; Dhalluin S; Ruty B; Rose G; Canning M
    Toxicol Sci; 2007 Mar; 96(1):101-14. PubMed ID: 17175557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptation of an in vitro phospholipidosis assay to an automated image analysis system.
    Schurdak ME; Vernetti LA; Abel SJ; Thiffault C
    Toxicol Mech Methods; 2007; 17(2):77-86. PubMed ID: 20020975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
    van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG
    Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential.
    Pelletier DJ; Gehlhaar D; Tilloy-Ellul A; Johnson TO; Greene N
    J Chem Inf Model; 2007; 47(3):1196-205. PubMed ID: 17428028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce Phospholipidosis.
    Gunesch AP; Zapatero-Belinchón FJ; Pinkert L; Steinmann E; Manns MP; Schneider G; Pietschmann T; Brönstrup M; von Hahn T
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Kruhlak NL; Choi SS; Contrera JF; Weaver JL; Willard JM; Hastings KL; Sancilio LF
    Toxicol Mech Methods; 2008; 18(2-3):217-27. PubMed ID: 20020916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation and validation of multiple cell lines and primary mouse macrophages to predict phospholipidosis potential.
    LeCureux L; Cheng CS; Herbst J; Reilly TP; Lehman-McKeeman L; Otieno M
    Toxicol In Vitro; 2011 Dec; 25(8):1934-43. PubMed ID: 21767630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromatography approaches for early screening of the phospholipidosis-inducing potential of pharmaceuticals.
    Jiang Z; Reilly J
    J Pharm Biomed Anal; 2012 Mar; 61():184-90. PubMed ID: 22200505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the Distribution Coefficient in Brain Polar Lipids for the Assessment of Drug-Induced Phospholipidosis Risk.
    Ceccarelli M; Wagner B; Alvarez-Sánchez R; Cruciani G; Goracci L
    Chem Res Toxicol; 2017 May; 30(5):1145-1156. PubMed ID: 28398727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosis.
    Doessegger L; Schmitt G; Lenz B; Fischer H; Schlotterbeck G; Atzpodien EA; Senn H; Suter L; Csato M; Evers S; Singer T
    Ther Adv Drug Saf; 2013 Jun; 4(3):101-14. PubMed ID: 25083254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for the drug-phospholipid interaction: correlation to phospholipidosis.
    Alakoskela JM; Vitovic P; Kinnunen PK
    ChemMedChem; 2009 Aug; 4(8):1224-51. PubMed ID: 19551800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.
    Sawada H; Takami K; Asahi S
    Toxicol Sci; 2005 Feb; 83(2):282-92. PubMed ID: 15342952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
    Desai PV; Sawada GA; Watson IA; Raub TJ
    Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure based model for the prediction of phospholipidosis induction potential of small molecules.
    Sun H; Shahane S; Xia M; Austin CP; Huang R
    J Chem Inf Model; 2012 Jul; 52(7):1798-805. PubMed ID: 22725677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase.
    Natalie M; Margino S; Erik H; Annelieke P; Geert V; Philippe V
    Toxicol In Vitro; 2009 Mar; 23(2):217-26. PubMed ID: 19101623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.